To investigate the mechanism by which CYH33 exhibits its anti-HNSCC activity, we interrogated the effect of CYH33 on the PI3K/Akt signaling in representative sensitive and resistant cells originated from different tissues. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.